Voyageur Pharmaceuticals Ltd. focuses on acquiring and developing raw materials for pharmaceutical products. The company faces significant concerns, including a low financial health score of 40/100, negative return on equity (-59.6%) and return on assets (-18.4%), indicating operational inefficiencies. Additionally, its liquidity ratios are concerning, with a current ratio of 0.33 and a quick ratio of 0.28, suggesting potential difficulties in meeting short-term obligations. However, a low debt-to-equity ratio of 0.04 indicates minimal leverage, which could provide some financial stability. Overall, the company requires substantial improvement in its financial performance.
Loading financial metrics...
Company has $378K in cash but burned $392K last quarter. At this burn rate, only 1.0 quarters of runway remain without additional financing.
Company posted a loss of $-2.2M over the last year, representing Infinity% of revenue.
Fortress balance sheet: cash covers total debt 9.5×, providing significant financial flexibility.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2025-Q2 (May 31, 2025)